Live Breaking News & Updates on Biopharmaceutical development

Stay informed with the latest breaking news from Biopharmaceutical development on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Biopharmaceutical development and stay connected to the pulse of your community

Mesa Laboratories, Inc. (NASDAQ:MLAB) Shares Bought by Motley Fool Asset Management LLC

Motley Fool Asset Management LLC boosted its stake in shares of Mesa Laboratories, Inc. (NASDAQ:MLAB – Free Report) by 9.8% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 8,709 shares of the medical instruments supplier’s stock after buying an additional 778 shares during the period. […]

United-states , Switzerland , America , Swiss , Asia-pacific , Motley-fool-asset-management , Sg-americas-securities , Nasdaq , Calibration-solutions , Jump-financial , Mesa-laboratories-inc , Swiss-national-bank

Conestoga Capital Advisors LLC Buys 48,253 Shares of Mesa Laboratories, Inc. (NASDAQ:MLAB)

Conestoga Capital Advisors LLC lifted its position in Mesa Laboratories, Inc. (NASDAQ:MLAB – Free Report) by 9.1% during the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 578,463 shares of the medical instruments supplier’s stock after purchasing an additional 48,253 shares during the period. Conestoga Capital Advisors LLC owned […]

United-states , Hong-kong , America , Asia-pacific , Calibration-solutions , Hong-kong-ltd , Conestoga-capital-advisors , Mesa-laboratories-inc , Nasdaq , Cubist-systematic-strategies , Biopharmaceutical-development , Tower-research-capital

Conestoga Capital Advisors LLC Has $60.61 Million Stock Holdings in Mesa Laboratories, Inc. (NASDAQ:MLAB)

Conestoga Capital Advisors LLC raised its position in Mesa Laboratories, Inc. (NASDAQ:MLAB – Free Report) by 9.1% during the fourth quarter, HoldingsChannel.com reports. The firm owned 578,463 shares of the medical instruments supplier’s stock after buying an additional 48,253 shares during the quarter. Conestoga Capital Advisors LLC owned approximately 0.11% of Mesa Laboratories worth $60,606,000 […]

United-states , America , Asia-pacific , Biopharmaceutical-development , Morgan-stanley , Comerica-bank , Conestoga-capital-advisors , Citadel-advisors , Glenmede-trust-co , Calibration-solutions , Nasdaq , Mesa-laboratories-inc

Mesa Laboratories (NASDAQ:MLAB) Shares Up 4.7%

Mesa Laboratories (NASDAQ:MLAB) Shares Up 4.7%
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United-states , America , Asia-pacific , Blackrock-inc , Biopharmaceutical-development , Nasdaq , Metlife-investment-management , Mesa-laboratories-company-profile , Citigroup-inc , Mesa-laboratories-inc , Calibration-solutions , Commonwealth-of-pennsylvania-public-school-empls-retrmt

Mesa Laboratories : Material Impairments - Form 8-K -April 02, 2024 at 01:44 pm EDT

ITEM 2.06 MATERIAL IMPAIRMENTS.

On April 1, 2024, Mesa Laboratories, Inc. concluded that a material charge for non-cash impairment losses related to goodwill and intangible...

China , Biopharmaceutical-development , Mesa-laboratories-inc , Mesa-laboratories , Clinical-genomics , Consolidated-statement ,

Biotechnology Reagents Market Share, Size, Trends, Forecast 2024-2032

Biotechnology Reagents Market Share, Size, Trends, Forecast 2024-2032
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

Brazil , Australia , United-kingdom , United-states , India , Russia , Spain , China , Brooklyn , New-south-wales , South-korea , Mexico

Mesa Laboratories, Inc. (NASDAQ:MLAB) Declares Quarterly Dividend of $0.16

Mesa Laboratories, Inc. (NASDAQ:MLAB – Get Free Report) declared a quarterly dividend on Tuesday, January 2nd, Zacks reports. Stockholders of record on Thursday, February 29th will be paid a dividend of 0.16 per share by the medical instruments supplier on Friday, March 15th. This represents a $0.64 dividend on an annualized basis and a dividend […]

United-states , Hong-kong , America , Asia-pacific , Brian-david-archbold , Tower-research-capital , Hong-kong-ltd , Biopharmaceutical-development , Nasdaq , Calibration-solutions , Mesa-laboratories-inc , Cubist-systematic-strategies

Kayne Anderson Rudnick Investment Management LLC Sells 2,430 Shares of Mesa Laboratories, Inc. (NASDAQ:MLAB)

Kayne Anderson Rudnick Investment Management LLC trimmed its holdings in Mesa Laboratories, Inc. (NASDAQ:MLAB – Free Report) by 1.7% in the third quarter, HoldingsChannel.com reports. The institutional investor owned 144,110 shares of the medical instruments supplier’s stock after selling 2,430 shares during the period. Kayne Anderson Rudnick Investment Management LLC’s holdings in Mesa Laboratories were […]

Hong-kong , United-states , America , Brian-david-archbold , Asia-pacific , Cubist-systematic-strategies , Tower-research-capital , Calibration-solutions , Mesa-laboratories-inc , Hong-kong-ltd , Securities-exchange-commission , Nasdaq

Mesa Laboratories, Inc. (NASDAQ:MLAB) Shares Sold by Kayne Anderson Rudnick Investment Management LLC

Kayne Anderson Rudnick Investment Management LLC cut its stake in shares of Mesa Laboratories, Inc. (NASDAQ:MLAB – Free Report) by 1.7% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 144,110 shares of the medical instruments supplier’s stock after selling 2,430 shares […]

United-states , America , Asia-pacific , Brian-david-archbold , Securities-exchange-commission , Nasdaq , Biopharmaceutical-development , Kayne-anderson-rudnick-investment-management , Vanguard-group-inc , Morgan-stanley , Mesa-laboratories-company-profile , Calibration-solutions

Kayne Anderson Rudnick Investment Management LLC Has $15.14 Million Position in Mesa Laboratories, Inc. (NASDAQ:MLAB)

Kayne Anderson Rudnick Investment Management LLC cut its stake in Mesa Laboratories, Inc. (NASDAQ:MLAB – Free Report) by 1.7% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 144,110 shares of the medical instruments supplier’s stock after selling 2,430 shares during the […]

United-states , America , Asia-pacific , Brian-david-archbold , Mesa-laboratories-inc , Biopharmaceutical-development , Commonwealth-of-pennsylvania-public-school-empls-retrmt , Calibration-solutions , Kayne-anderson-rudnick-investment-management , Securities-exchange-commission , Nasdaq , Blackrock-inc